| Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction SR Yurista, HHW Silljé, SU Oberdorf‐Maass, EM Schouten, ... European journal of heart failure 21 (7), 862-873, 2019 | 324 | 2019 |
| Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC Focus Seminar SR Yurista, CR Chong, JJ Badimon, DP Kelly, RA de Boer, ... Journal of the American College of Cardiology, 2021 | 179* | 2021 |
| Ketone ester treatment improves cardiac function and reduces pathologic remodeling in preclinical models of heart failure SR Yurista, TR Matsuura, HHW Silljé, KT Nijholt, KS McDaid, SV Shewale, ... Circulation: Heart Failure 14 (1), e007684, 2021 | 134 | 2021 |
| Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes. JACC Basic to Transl Sci. 2019; 4: 831–840 O Iborra-Egea, E Santiago-Vacas, SR Yurista, J Lupón, M Packer, ... Přejít k původnímu zdroji, 0 | 107* | |
| Unraveling the molecular mechanism of action of empagliflozin in heart failure with reduced ejection fraction with or without diabetes O Iborra-Egea, E Santiago-Vacas, SR Yurista, J Lupón, M Packer, ... JACC: Basic to Translational Science 4 (7), 831-840, 2019 | 104 | 2019 |
| SGLT2 Inhibitors and Ketone Metabolism in Heart Failure H Saucedo-Orozco, SN Voorrips, SR Yurista, RA de Boer, ... Journal of Lipid and Atherosclerosis 11 (1), 1, 2022 | 49 | 2022 |
| Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes? SR Yurista, HHW Silljé, M Rienstra, RA de Boer, BD Westenbrink Cardiovascular diabetology 19 (1), 1-7, 2020 | 39 | 2020 |
| Ketone bodies for the failing heart: fuels that can fix the engine? SR Yurista, CT Nguyen, A Rosenzweig, RA de Boer, BD Westenbrink Trends in Endocrinology & Metabolism, 2021 | 38 | 2021 |
| A soft robotic sleeve mimicking the haemodynamics and biomechanics of left ventricular pressure overload and aortic stenosis L Rosalia, C Ozturk, J Coll-Font, Y Fan, Y Nagata, M Singh, D Goswami, ... Nature Biomedical Engineering, 1-14, 2022 | 31 | 2022 |
| The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise KT Nijholt, LMG Meems, WPT Ruifrok, AH Maass, SR Yurista, ... Pflügers Archiv-European Journal of Physiology, 1-13, 2021 | 20 | 2021 |
| Effects of sodium–glucose co-transporter 2 inhibition with empaglifozin on renal structure and function in non-diabetic rats with left ventricular dysfunction after myocardial … SR Yurista, HHW Silljé, H van Goor, JL Hillebrands, HJL Heerspink, ... Cardiovascular drugs and therapy 34 (3), 311, 2020 | 20 | 2020 |
| Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time? SR Yurista, S Chen, A Welsh, WH Tang, CT Nguyen Current Heart Failure Reports, 1-11, 2022 | 18 | 2022 |
| Ketone ester supplementation suppresses cardiac inflammation and improves cardiac energetics in a swine model of acute myocardial infarction SR Yurista, RA Eder, A Welsh, W Jiang, S Chen, AN Foster, A Mauskapf, ... Metabolism, 155608, 2023 | 15 | 2023 |
| Contrast‐Enhanced Cardiac Magnetic Resonance Imaging With a Manganese‐Based Alternative to Gadolinium for Tissue Characterization of Acute Myocardial Infarction BP Bonner, SR Yurista, J Coll‐Font, S Chen, RA Eder, AN Foster, ... Journal of the American Heart Association 12 (8), e026923, 2023 | 14 | 2023 |
| ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ MG Pavez-Giani, PI Sánchez-Aguilera, N Bomer, S Miyamoto, HG Booij, ... International journal of molecular sciences 22 (9), 4427, 2021 | 14 | 2021 |
| A Closer Look at ACC/AHA and ESC Guidelines for Managing Obesity and Overweight in Adults SR Yurista, RA Eder, M Feeley, N Kodur, WHW Tang, CT Nguyen JACC: Advances 2 (7), 100570, 2023 | 9 | 2023 |
| Magnetic resonance imaging of cardiac metabolism in heart failure: how far have we come? SR Yurista, RA Eder, DH Kwon, CT Farrar, YF Yen, WH Tang, CT Nguyen European Heart Journal-Cardiovascular Imaging, 2022 | 9 | 2022 |
| Factor Xa inhibition with apixaban does not influence cardiac remodelling in rats with heart failure after myocardial infarction SR Yurista, HHW Silljé, KT Nijholt, MM Dokter, DJ van Veldhuisen, ... Cardiovascular drugs and therapy 35 (5), 953-963, 2021 | 7 | 2021 |
| Ketogenic Diet in Heart Failure: Fact or Fiction? N Kodur, S Yurista, V Province, E Rueth, C Nguyen, WHW Tang Heart Failure 11 (7), 838-844, 2023 | 6 | 2023 |
| Ketone Bodies: Universal Cardiac Response to Stress? SR Yurista, A Rosenzweig, CT Nguyen Journal of the American College of Cardiology 78 (14), 1433-1436, 2021 | 6 | 2021 |
